{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:11:54Z","timestamp":1777126314750,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alport syndrome is an inherited chronic human kidney disease, characterized by glomerular basement membrane abnormalities. This disease is caused by mutations in\n                    <jats:italic>COL4A3<\/jats:italic>\n                    ,\n                    <jats:italic>COL4A4<\/jats:italic>\n                    , or\n                    <jats:italic>COL4A5<\/jats:italic>\n                    gene. The knockout mice for\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>3<\/jats:italic>\n                    ,\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>4<\/jats:italic>\n                    , and\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>5<\/jats:italic>\n                    are developed and well characterized for the study of Alport syndrome. However, disease progression and effects of pharmacological therapy depend on the genetic variability. This model was reliable only to mouse. In this study, we created a novel Alport syndrome rat model utilizing the rGONAD technology, which generated rat with a deletion of the\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>5<\/jats:italic>\n                    gene.\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>5<\/jats:italic>\n                    deficient rats showed hematuria, proteinuria, high levels of BUN, Cre, and then died at 18 to 28\u00a0weeks of age (Hemizygous mutant males). Histological and ultrastructural analyses displayed the abnormalities including parietal cell hyperplasia, mesangial sclerosis, and interstitial fibrosis. Then, we demonstrated that \u03b13\/\u03b14\/\u03b15 (IV) and \u03b15\/\u03b15\/\u03b16 (IV) chains of type IV collagen disrupted in\n                    <jats:italic>Col4\u03b15<\/jats:italic>\n                    deficient rats. Thus,\n                    <jats:italic>Col4<\/jats:italic>\n                    \u03b1\n                    <jats:italic>5<\/jats:italic>\n                    mutant rat is a reliable candidate for the Alport syndrome model for underlying the mechanism of kidney diseases and further identifying potential therapeutic targets for human renal diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-00354-y","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T06:04:42Z","timestamp":1634796282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Creation of X-linked Alport syndrome rat model with Col4a5 deficiency"],"prefix":"10.1038","volume":"11","author":[{"given":"Masumi","family":"Namba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Koyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.matbio.2016.08.005","volume":"57\u201358","author":"D Cosgrove","year":"2017","unstructured":"Cosgrove, D. & Liu, S. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. Matrix Biol. 57\u201358, 45\u201354. https:\/\/doi.org\/10.1016\/j.matbio.2016.08.005 (2017).","journal-title":"Matrix Biol."},{"key":"354_CR2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.203950","author":"AL Fidler","year":"2018","unstructured":"Fidler, A. L., Boudko, S. P., Rokas, A. & Hudson, B. G. The triple helix of collagens: An ancient protein structure that enabled animal multicellularity and tissue evolution. J. Cell Sci. https:\/\/doi.org\/10.1242\/jcs.203950 (2018).","journal-title":"J. Cell Sci."},{"key":"354_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1083\/jcb.130.5.1219","volume":"130","author":"Y Ninomiya","year":"1995","unstructured":"Ninomiya, Y. et al. Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J. Cell Biol. 130, 1219\u20131229. https:\/\/doi.org\/10.1083\/jcb.130.5.1219 (1995).","journal-title":"J. Cell Biol."},{"key":"354_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel, J., Rubel, D. & Gross, O. Alport syndrome\u2013insights from basic and clinical research. Nat. Rev. Nephrol. 9, 170\u2013178. https:\/\/doi.org\/10.1038\/nrneph.2012.259 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan, C. E. et al. Alport syndrome: A unified classification of genetic disorders of collagen IV alpha345: A position paper of the Alport Syndrome Classification Working Group. Kidney Int. 93, 1045\u20131051. https:\/\/doi.org\/10.1016\/j.kint.2017.12.018 (2018).","journal-title":"Kidney Int."},{"key":"354_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2009070784","volume":"21","author":"MR Bekheirnia","year":"2010","unstructured":"Bekheirnia, M. R. et al. Genotype-phenotype correlation in X-linked Alport syndrome. J. Am. Soc. Nephrol. 21, 876\u2013883. https:\/\/doi.org\/10.1681\/ASN.2009070784 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","volume":"10","author":"D Cosgrove","year":"1996","unstructured":"Cosgrove, D. et al. Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev. 10, 2981\u20132992. https:\/\/doi.org\/10.1101\/gad.10.23.2981 (1996).","journal-title":"Genes Dev."},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","volume":"135","author":"JH Miner","year":"1996","unstructured":"Miner, J. H. & Sanes, J. R. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): Implications for Alport syndrome. J. Cell Biol. 135, 1403\u20131413. https:\/\/doi.org\/10.1083\/jcb.135.5.1403 (1996).","journal-title":"J. Cell Biol."},{"key":"354_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ki.2013.493","volume":"85","author":"R Korstanje","year":"2014","unstructured":"Korstanje, R. et al. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen alpha3alpha4alpha5(IV) trimers. Kidney Int. 85, 1461\u20131468. https:\/\/doi.org\/10.1038\/ki.2013.493 (2014).","journal-title":"Kidney Int."},{"key":"354_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/01.asn.0000130562.90255.8f","volume":"15","author":"MN Rheault","year":"2004","unstructured":"Rheault, M. N. et al. Mouse model of X-linked Alport syndrome. J. Am. Soc. Nephrol. 15, 1466\u20131474. https:\/\/doi.org\/10.1097\/01.asn.0000130562.90255.8f (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"354_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbrep.2018.12.003","volume":"17","author":"K Hashikami","year":"2019","unstructured":"Hashikami, K. et al. Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation. Biochem. Biophys. Rep. 17, 81\u201386. https:\/\/doi.org\/10.1016\/j.bbrep.2018.12.003 (2019).","journal-title":"Biochem. Biophys. Rep."},{"key":"354_CR12","doi-asserted-by":"publisher","first-page":"18891","DOI":"10.1038\/s41598-020-76068-4","volume":"10","author":"JY Song","year":"2020","unstructured":"Song, J. Y. et al. Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5. Sci. Rep. 10, 18891. https:\/\/doi.org\/10.1038\/s41598-020-76068-4 (2020).","journal-title":"Sci. Rep."},{"key":"354_CR13","doi-asserted-by":"publisher","first-page":"29450","DOI":"10.1038\/srep29450","volume":"6","author":"T Murata","year":"2016","unstructured":"Murata, T. et al. COL4A6 is dispensable for autosomal recessive Alport syndrome. Sci. Rep. 6, 29450. https:\/\/doi.org\/10.1038\/srep29450 (2016).","journal-title":"Sci. Rep."},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"20398","DOI":"10.1038\/s41598-019-56837-6","volume":"9","author":"S Falcone","year":"2019","unstructured":"Falcone, S. et al. Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic background. Sci. Rep. 9, 20398. https:\/\/doi.org\/10.1038\/s41598-019-56837-6 (2019).","journal-title":"Sci. Rep."},{"key":"354_CR15","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1681\/ASN.2006020165","volume":"17","author":"JS Kang","year":"2006","unstructured":"Kang, J. S. et al. Loss of alpha3\/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-\/- Alport mice. J. Am. Soc. Nephrol. 17, 1962\u20131969. https:\/\/doi.org\/10.1681\/ASN.2006020165 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"354_CR16","first-page":"175","volume":"116","author":"B Jansen","year":"1984","unstructured":"Jansen, B. et al. Animal model of human disease: Hereditary nephritis in Samoyed dogs. Am. J. Pathol. 116, 175\u2013178 (1984).","journal-title":"Am. J. Pathol."},{"key":"354_CR17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2013.06.040","volume":"154","author":"SS Atanur","year":"2013","unstructured":"Atanur, S. S. et al. Genome sequencing reveals loci under artificial selection that underlie disease phenotypes in the laboratory rat. Cell 154, 691\u2013703. https:\/\/doi.org\/10.1016\/j.cell.2013.06.040 (2013).","journal-title":"Cell"},{"key":"354_CR18","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.027276","author":"LJ Mullins","year":"2016","unstructured":"Mullins, L. J., Conway, B. R., Menzies, R. I., Denby, L. & Mullins, J. J. Renal disease pathophysiology and treatment: Contributions from the rat. Dis. Model Mech. https:\/\/doi.org\/10.1242\/dmm.027276 (2016).","journal-title":"Dis. Model Mech."},{"key":"354_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-017-0346-2","author":"K Yoshimi","year":"2017","unstructured":"Yoshimi, K. & Mashimo, T. Application of genome editing technologies in rats for human disease models. J. Hum Genet. https:\/\/doi.org\/10.1038\/s10038-017-0346-2 (2017).","journal-title":"J. Hum Genet."},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature04489","volume":"439","author":"TJ Aitman","year":"2006","unstructured":"Aitman, T. J. et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439, 851\u2013855. https:\/\/doi.org\/10.1038\/nature04489 (2006).","journal-title":"Nature"},{"key":"354_CR21","first-page":"193","volume":"19","author":"Y Sado","year":"1986","unstructured":"Sado, Y., Naito, I., Akita, M. & Okigaki, T. Strain specific responses of inbred rats on the severity of experimental autoimmune glomerulonephritis. J. Clin. Lab. Immunol. 19, 193\u2013199 (1986).","journal-title":"J. Clin. Lab. Immunol."},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/path.1711680211","volume":"168","author":"Y Sado","year":"1992","unstructured":"Sado, Y. et al. Isologous monoclonal antibodies can induce anti-GBM glomerulonephritis in rats. J. Pathol. 168, 221\u2013227. https:\/\/doi.org\/10.1002\/path.1711680211 (1992).","journal-title":"J. Pathol."},{"key":"354_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1046\/j.1523-1755.1998.00795.x","volume":"53","author":"Y Sado","year":"1998","unstructured":"Sado, Y. et al. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen. Kidney Int. 53, 664\u2013671. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00795.x (1998).","journal-title":"Kidney Int."},{"key":"354_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00335-017-9705-8","volume":"28","author":"S Meek","year":"2017","unstructured":"Meek, S., Mashimo, T. & Burdon, T. From engineering to editing the rat genome. Mamm. Genome 28, 302\u2013314. https:\/\/doi.org\/10.1007\/s00335-017-9705-8 (2017).","journal-title":"Mamm. Genome"},{"key":"354_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12929-020-00673-8","volume":"27","author":"C Szpirer","year":"2020","unstructured":"Szpirer, C. Rat models of human diseases and related phenotypes: A systematic inventory of the causative genes. J. Biomed. Sci. 27, 84. https:\/\/doi.org\/10.1186\/s12929-020-00673-8 (2020).","journal-title":"J. Biomed. Sci."},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1038\/srep11406","volume":"5","author":"G Takahashi","year":"2015","unstructured":"Takahashi, G. et al. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: A novel microinjection independent genome engineering method in mice. Sci. Rep. 5, 11406. https:\/\/doi.org\/10.1038\/srep11406 (2015).","journal-title":"Sci. Rep."},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13059-018-1400-x","volume":"19","author":"M Ohtsuka","year":"2018","unstructured":"Ohtsuka, M. et al. i-GONAD: A robust method for in situ germline genome engineering using CRISPR nucleases. Genome Biol. 19, 25. https:\/\/doi.org\/10.1186\/s13059-018-1400-x (2018).","journal-title":"Genome Biol."},{"key":"354_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12896-018-0430-5","volume":"18","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi, T. et al. Successful production of genome-edited rats by the rGONAD method. BMC Biotechnol. 18, 19. https:\/\/doi.org\/10.1186\/s12896-018-0430-5 (2018).","journal-title":"BMC Biotechnol."},{"key":"354_CR29","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/s41596-019-0187-x","volume":"14","author":"CB Gurumurthy","year":"2019","unstructured":"Gurumurthy, C. B. et al. Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD. Nat. Protoc. 14, 2452\u20132482. https:\/\/doi.org\/10.1038\/s41596-019-0187-x (2019).","journal-title":"Nat. Protoc."},{"key":"354_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/dgd.12746","author":"M Namba","year":"2021","unstructured":"Namba, M. et al. GONAD: A new method for germline genome-editing in mice and rats. Dev. Growth Differ. https:\/\/doi.org\/10.1111\/dgd.12746 (2021).","journal-title":"Dev. Growth Differ."},{"key":"354_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2220\/biomedres.35.345","volume":"35","author":"S Okada","year":"2014","unstructured":"Okada, S. et al. Morphological diagnosis of Alport syndrome and thin basement membrane nephropathy by low vacuum scanning electron microscopy. Biomed. Res. 35, 345\u2013350. https:\/\/doi.org\/10.2220\/biomedres.35.345 (2014).","journal-title":"Biomed. Res."},{"key":"354_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/s0002-9440(10)64802-x","volume":"157","author":"D Cosgrove","year":"2000","unstructured":"Cosgrove, D. et al. Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am. J. Pathol. 157, 1649\u20131659. https:\/\/doi.org\/10.1016\/s0002-9440(10)64802-x (2000).","journal-title":"Am. J. Pathol."},{"key":"354_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1681\/ASN.V122252","volume":"12","author":"CE Kashtan","year":"2001","unstructured":"Kashtan, C. E. et al. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: Aberrant laminin alpha2 deposition is species independent. J. Am. Soc. Nephrol. 12, 252\u2013260. https:\/\/doi.org\/10.1681\/ASN.V122252 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"354_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/ki.2009.324","volume":"76","author":"DT Meehan","year":"2009","unstructured":"Meehan, D. T. et al. Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease. Kidney Int. 76, 968\u2013976. https:\/\/doi.org\/10.1038\/ki.2009.324 (2009).","journal-title":"Kidney Int."},{"key":"354_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/ndt\/gfl810","volume":"22","author":"ML Koepke","year":"2007","unstructured":"Koepke, M. L. et al. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome. Nephrol. Dial. Transpl. 22, 1062\u20131069. https:\/\/doi.org\/10.1093\/ndt\/gfl810 (2007).","journal-title":"Nephrol. Dial. Transpl."},{"key":"354_CR36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94818","author":"W Ding","year":"2018","unstructured":"Ding, W. et al. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.94818 (2018).","journal-title":"JCI Insight"},{"key":"354_CR37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1681\/ASN.2004100871","volume":"16","author":"V Ninichuk","year":"2005","unstructured":"Ninichuk, V. et al. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J. Am. Soc. Nephrol. 16, 977\u2013985. https:\/\/doi.org\/10.1681\/ASN.2004100871 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"354_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.kint.2018.02.024","volume":"94","author":"D Cosgrove","year":"2018","unstructured":"Cosgrove, D. et al. Lysyl oxidase like-2 contributes to renal fibrosis in Col4alpha3\/Alport mice. Kidney Int. 94, 303\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2018.02.024 (2018).","journal-title":"Kidney Int."},{"key":"354_CR39","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.1038\/s41598-021-86109-1","volume":"11","author":"K Omachi","year":"2021","unstructured":"Omachi, K. et al. Metformin ameliorates the severity of experimental Alport syndrome. Sci. Rep. 11, 7053. https:\/\/doi.org\/10.1038\/s41598-021-86109-1 (2021).","journal-title":"Sci. Rep."},{"key":"354_CR40","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","volume":"160","author":"KL Andrews","year":"2002","unstructured":"Andrews, K. L., Mudd, J. L., Li, C. & Miner, J. H. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am. J. Pathol. 160, 721\u2013730. https:\/\/doi.org\/10.1016\/S0002-9440(10)64892-4 (2002).","journal-title":"Am. J. Pathol."},{"key":"354_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ndt\/gfn722","volume":"24","author":"O Gross","year":"2009","unstructured":"Gross, O. et al. Stem cell therapy for Alport syndrome: The hope beyond the hype. Nephrol. Dial. Transpl. 24, 731\u2013734. https:\/\/doi.org\/10.1093\/ndt\/gfn722 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"354_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O Gross","year":"2003","unstructured":"Gross, O. et al. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int. 63, 438\u2013446. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00779.x (2003).","journal-title":"Kidney Int."},{"key":"354_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9581-3_1","volume":"2018","author":"JR Smith","year":"2019","unstructured":"Smith, J. R., Bolton, E. R. & Dwinell, M. R. The rat: A model used in biomedical research. Methods Mol. Biol. 2018, 1\u201341. https:\/\/doi.org\/10.1007\/978-1-4939-9581-3_1 (2019).","journal-title":"Methods Mol. Biol."},{"key":"354_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60327-389-3_1","volume":"597","author":"HJ Jacob","year":"2010","unstructured":"Jacob, H. J. The rat: A model used in biomedical research. Methods Mol. Biol. 597, 1\u201311. https:\/\/doi.org\/10.1007\/978-1-60327-389-3_1 (2010).","journal-title":"Methods Mol. Biol."},{"key":"354_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1242\/dmm.027706","volume":"9","author":"T Aitman","year":"2016","unstructured":"Aitman, T., Dhillon, P. & Geurts, A. M. A RATional choice for translational research?. Dis. Model Mech. 9, 1069\u20131072. https:\/\/doi.org\/10.1242\/dmm.027706 (2016).","journal-title":"Dis. Model Mech."},{"key":"354_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1901\/jeab.1996.65-129","volume":"65","author":"MH Hunziker","year":"1996","unstructured":"Hunziker, M. H., Saldana, R. L. & Neuringer, A. Behavioral variability in SHR and WKY rats as a function of rearing environment and reinforcement contingency. J. Exp. Anal. Behav. 65, 129\u2013144. https:\/\/doi.org\/10.1901\/jeab.1996.65-129 (1996).","journal-title":"J. Exp. Anal. Behav."},{"key":"354_CR47","doi-asserted-by":"publisher","first-page":"31526","DOI":"10.1074\/jbc.M114.584565","volume":"289","author":"M Matsuyama","year":"2014","unstructured":"Matsuyama, M., Nomori, A., Nakakuni, K., Shimono, A. & Fukushima, M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J. Biol. Chem. 289, 31526\u201331533. https:\/\/doi.org\/10.1074\/jbc.M114.584565 (2014).","journal-title":"J. Biol. Chem."},{"key":"354_CR48","doi-asserted-by":"publisher","first-page":"16808","DOI":"10.1038\/s41598-018-35162-4","volume":"8","author":"S Shimada","year":"2018","unstructured":"Shimada, S. et al. Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model. Sci. Rep. 8, 16808. https:\/\/doi.org\/10.1038\/s41598-018-35162-4 (2018).","journal-title":"Sci. Rep."},{"key":"354_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1247\/csf.20.151","volume":"20","author":"Y Kishiro","year":"1995","unstructured":"Kishiro, Y., Kagawa, M., Naito, I. & Sado, Y. A novel method of preparing rat-monoclonal antibody-producing hybridomas by using rat medial iliac lymph node cells. Cell Struct. Funct. 20, 151\u2013156. https:\/\/doi.org\/10.1247\/csf.20.151 (1995).","journal-title":"Cell Struct. Funct."},{"key":"354_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1267\/ahc.06001","volume":"39","author":"Y Sado","year":"2006","unstructured":"Sado, Y., Inoue, S., Tomono, Y. & Omori, H. Lymphocytes from enlarged iliac lymph nodes as fusion partners for the production of monoclonal antibodies after a single tail base immunization attempt. Acta Histochem. Cytochem. 39, 89\u201394. https:\/\/doi.org\/10.1267\/ahc.06001 (2006).","journal-title":"Acta Histochem. Cytochem."},{"key":"354_CR51","doi-asserted-by":"publisher","first-page":"35626","DOI":"10.1074\/jbc.M113.514737","volume":"288","author":"M Matsuyama","year":"2013","unstructured":"Matsuyama, M. et al. Defect of mitotic vimentin phosphorylation causes microophthalmia and cataract via aneuploidy and senescence in lens epithelial cells. J. Biol. Chem. 288, 35626\u201335635. https:\/\/doi.org\/10.1074\/jbc.M113.514737 (2013).","journal-title":"J. Biol. Chem."},{"key":"354_CR52","doi-asserted-by":"publisher","first-page":"12059","DOI":"10.1038\/s41598-019-48557-8","volume":"9","author":"T Koyano","year":"2019","unstructured":"Koyano, T. et al. The p21 dependent G2 arrest of the cell cycle in epithelial tubular cells links to the early stage of renal fibrosis. Sci. Rep. 9, 12059. https:\/\/doi.org\/10.1038\/s41598-019-48557-8 (2019).","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1038\/s41598-021-01409-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00354-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:51:30Z","timestamp":1670068290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00354-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00354-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.13.439726","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-01409-w","URL":"https:\/\/doi.org\/10.1038\/s41598-021-01409-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20836"}}